Double-blind Comparative Study of TAK-875

Status:
Completed

Trial end date:
2012-09-01

Target enrollment:

Participant gender:

The purpose of this study is to evaluate the efficacy and safety of treatment with TAK-875 in diabetic patients.

Phase 3

Takeda